SCHEMBL3884149

SCHEMBL3884149

COC(=O)CCc1ccc(OCCc2cccc(Cl)c2)c(-c2ccc3[nH]ccc3c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 1/20 0.41
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 1/20 0.41
ENPP2 Q13822 1/20 0.41
TP53 P04637 2/20 0.40
MDM2 Q00987 2/20 0.40
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
HTR2B P41595 1/20 0.39
HTR6 P50406 1/20 0.39
MAPT P10636 1/20 0.39
LPAR1 Q92633 1/20 0.39
FLT3 P36888 1/20 0.39
SLC6A9 P48067 1/20 0.38
PDE4D Q08499 1/20 0.38
MCHR1 Q99705 1/20 0.38
PTPN1 P18031 1/20 0.38
NR4A2 P43354 2/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3881183 0.93 FFAR4 (0.49) CDK8FFAR1FFAR4ENPP2TP53
SCHEMBL3884061 0.92 MAPT (0.41) FFAR1ENPP2TP53MDM2HTR2C
SCHEMBL27627113 0.91 ENPP2 (0.48) CDK8ENPP2TP53MDM2PDE4D
SCHEMBL3884965 0.90 ENPP2 (0.41) CDK8FFAR4ENPP2LPAR1PTPN1
SCHEMBL3880827 0.90 FFAR1 (0.49) CDK8FFAR1FFAR4ENPP2TP53
SCHEMBL3884677 0.88 KMT2A (0.42) CDK8FFAR1FFAR4ENPP2MAPT
SCHEMBL3882480 0.87 CCNC (0.46) CDK8FFAR4ENPP2PTPN1HDAC1
SCHEMBL3882078 0.87 HDAC1 (0.39) CDK8FFAR4ENPP2FLT3PTPN1
SCHEMBL3885515 0.86 ALDH1A1 (0.43) CDK8FFAR1FFAR4ENPP2MAPT
SCHEMBL3882445 0.86 HDAC1 (0.41) FFAR1FFAR4ENPP2TP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 CDK8 3600/4885FFAR1 13/4885FFAR4 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.